219 related articles for article (PubMed ID: 22811512)
21. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Tomita E; Takase H; Tajima K; Suematsu Y
Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
[TBL] [Abstract][Full Text] [Related]
22. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
[TBL] [Abstract][Full Text] [Related]
23. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
[TBL] [Abstract][Full Text] [Related]
24. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
[TBL] [Abstract][Full Text] [Related]
25. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
[TBL] [Abstract][Full Text] [Related]
26. [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].
Ingimarsson JP; Onundarson PT; Valsson F; Vidarsson B; Gudbjartsson T
Laeknabladid; 2008 Sep; 94(9):607-12. PubMed ID: 18784387
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of recombinant activated factor VII for massive bleeding after cardiac surgery: experience with 32 patients].
Millán C; Quintana B; Rodríguez A; Iglesias M; Barranco M; Navia J
Rev Esp Anestesiol Reanim; 2009 Oct; 56(8):485-92. PubMed ID: 19994617
[TBL] [Abstract][Full Text] [Related]
28. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
[TBL] [Abstract][Full Text] [Related]
29. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
[TBL] [Abstract][Full Text] [Related]
30. Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.
Hollis AL; Lowery AV; Pajoumand M; Pham SM; Slejko JF; Tanaka KA; Mazzeffi M
Ann Card Anaesth; 2016; 19(3):418-24. PubMed ID: 27397445
[TBL] [Abstract][Full Text] [Related]
31. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
32. Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection.
Zindovic I; Sjögren J; Ahlsson A; Bjursten H; Fuglsang S; Geirsson A; Ingemansson R; Hansson EC; Mennander A; Olsson C; Pan E; Ullén S; Gudbjartsson T; Nozohoor S
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1852-1859.e2. PubMed ID: 28967418
[TBL] [Abstract][Full Text] [Related]
33. Factor VII for excessive bleeding following congenital heart disease surgery.
Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
[TBL] [Abstract][Full Text] [Related]
34. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
35. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
36. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
[TBL] [Abstract][Full Text] [Related]
37. Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes.
Willis C; Bird R; Mullany D; Cameron P; Phillips L
Vox Sang; 2010 May; 98(4):531-7. PubMed ID: 19878495
[TBL] [Abstract][Full Text] [Related]
38. Recombinant activated factor VII following pediatric cardiac surgery.
Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
[TBL] [Abstract][Full Text] [Related]
39. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
Wittenstein B; Ng C; Ravn H; Goldman A
Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
[TBL] [Abstract][Full Text] [Related]
40. Recombinant activated factor VII in cardiac surgery: a meta-analysis.
Zangrillo A; Mizzi A; Biondi-Zoccai G; Bignami E; Calabrò MG; Pappalardo F; Dedola E; Tritapepe L; Marino G; Landoni G
J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):34-40. PubMed ID: 19081268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
